TreeFrog Therapeutics has been named one of Hello Tomorrow’s Deep Tech Pioneers! Selected among more than 5,000 startups from 128 different countries that applied to the Global Challenge. Come and meet us at the Hello Tomorrow Global Summit in Paris on 12th-13th March 2020!...
TreeFrog Therapeutics－すべての人に細胞治療を（幹細胞治療の会社）https://youtu.be/F_q_dp5iNA8 C-Stem™：幹細胞のカプセル化のメカニズムについて（TreeFrog Therapeutics）https://youtu.be/L3FxGlLKVsM 幹細胞の大量生産のメカニズムについてhttps://youtu.be/e4CbJv0T_ug C-Stem™：細胞治療のコスト削減のメカニズムについてhttps://youtu.be/OcfDgqEftE4...
TreeFrog Therapeutics’ CEO/CTO, Kevin Alessandri is spending a week in Boston (Novembre 4-9) as part of the New Technology Venture Accelerator (NETVA) program to meet the local deep tech ecosystem.Thanks to the teams of the Science and Technology Department of the French Embassy in the United States who...
https://youtu.be/Fqn098sYBzcOur CSO, Maxime Feyeux, contributed to a roundtable entitled “What breakthrough innovations to develop next-generation bioproduction factories ?” organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event....
TreeFrog Therapeutics was Japan from the 10th to 21th of September 2019 to meet key academic and industry players. Notably, our team gave a presentation at the mecca of iPS : the Center for iPS Cell Research and Application (CiRA), Kyoto University. And on September 18th, Maxime Feyeux,...
TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021 Company awarded close to €3M ($3.3M) in public grants only five months after Series A round of €7M ($7.8M) Bordeaux, France, September 5, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces...
https://youtu.be/e4CbJv0T_ugTreeFrog Therapeutics has developed C-Stem™ : a proprietary technology platform for the mass-production of iPSc-based cell therapies.C-Stem™ secures cell quality (100% genomic integrity), volumes (x100 cell amplification per week) and dramatically reduces cell therapy costs (by 10 today, by 100 tomorrow).Learn about C-Stem...
TreeFrog will be in Japan from the 10th to 21th of September 2019 to meet key academic and industry players ! This cell therapy roadtrip, organized with the help of Business France, will be marked by our participation to Cell Therapy Word Asia 2019 on Sept 18-19 !...
Kevin Alessandri, CEO/CTO of TreeFrog was cited in a recent article of Labiotech.eu on the current obstacles preventing cell therapies to become mainstream. Read more...